Date de publication: 3 mai 2021
Promoteur – Intermédiaire FinancierDRAEGERWERK AG & CO KGAA
The project concerns the Promoter's corporate research and development (R&D) programme in its medical division for the period 2021-2023, with a particular focus on connected health devices.
The project's emphasis on connected health devices follows the trend of therapy automation in hospitals through diagnostic and therapeutic assistance systems. Since the outbreak of COVID-19, the relevance and demand for connected health devices has significantly increased.
- Industrie - Industrie manufacturière
Montant BEI envisagé (montant approximatif)
EUR 100 million
Coût total (montant approximatif)
EUR 225 million
The project concerns investments in research and development that are expected to be carried out in existing facilities, already authorised, and which would therefore not require an environmental impact assessment (EIA) 2014/52/EU amending the EIA Directive 2011/92/EC. Full environmental details will be verified during the appraisal.
Passation des marchés
The Promoter is a private company not operating in the utilities sector, and is thus not covered by EU directives on procurement.
Signé - 14/04/2021